Prioritizing context-specific genetic risk mechanisms in 11 solid cancers
Mapping where cancer genes act in specific cell types could help researchers design more targeted prevention and treatment strategies.
Researchers applied CT-FM, a novel computational method integrating 1,473 context-specific regulatory annotations with GWAS data from ~48,000 cancer cases across 11 solid tumors, to identify the specific cell types and tissues where cancer-associated genetic variants act. Four high-confidence biological contexts were prioritized at genome-wide level, and 489 regulatory quadruplets were constructed, providing testable mechanistic hypotheses for cancer genetic susceptibility.
What the study was
- Study design
- Integrative genomics / GWAS meta-analysis
- Population
- European ancestry cancer GWAS cohorts, 11 solid cancers (breast, prostate, colorectal, endometrial, lung, bladder, renal, others)
- Sample size
- avg 47856 cases per cancer
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Journal of the National Cancer Institute
Why it surfaced
Top-tier JNCI publication; novel CT-FM computational framework integrating GWAS + cis-regulatory annotations for 11 cancers with large-scale samples; 489 regulatory quadruplets provide actionable mechanistic hypotheses; high methodological quality and multi-cancer scope.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.